Zhiguo Lin

2.0k total citations · 1 hit paper
71 papers, 1.3k citations indexed

About

Zhiguo Lin is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Zhiguo Lin has authored 71 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 19 papers in Cancer Research and 12 papers in Genetics. Recurrent topics in Zhiguo Lin's work include Glioma Diagnosis and Treatment (12 papers), MicroRNA in disease regulation (12 papers) and Ferroptosis and cancer prognosis (9 papers). Zhiguo Lin is often cited by papers focused on Glioma Diagnosis and Treatment (12 papers), MicroRNA in disease regulation (12 papers) and Ferroptosis and cancer prognosis (9 papers). Zhiguo Lin collaborates with scholars based in China, United States and Canada. Zhiguo Lin's co-authors include Hong Shen, Minwei Zhu, Zhenfeng Jiang, Na Meng, Anhua Wu, Cunyi Zou, Gefei Guan, Shuai Shen, Tianqi Liu and Chen Zhu and has published in prestigious journals such as Journal of Clinical Oncology, Brain Research and Clinical Cancer Research.

In The Last Decade

Zhiguo Lin

67 papers receiving 1.2k citations

Hit Papers

Ferroptosis, as the most enriched programmed cell death p... 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhiguo Lin China 21 593 368 240 228 214 71 1.3k
Shin-Hyuk Kang South Korea 21 678 1.1× 240 0.7× 147 0.6× 388 1.7× 215 1.0× 44 1.7k
Yuanqing Yan United States 25 634 1.1× 351 1.0× 146 0.6× 213 0.9× 119 0.6× 57 1.5k
Stéphan Saïkali France 23 701 1.2× 372 1.0× 205 0.9× 303 1.3× 260 1.2× 61 1.9k
Chuanlu Jiang China 23 887 1.5× 602 1.6× 187 0.8× 199 0.9× 181 0.8× 48 1.6k
Abhik Ray‐Chaudhury United States 22 943 1.6× 557 1.5× 123 0.5× 226 1.0× 81 0.4× 55 1.8k
Markéta Hermanová Czechia 23 751 1.3× 437 1.2× 98 0.4× 481 2.1× 209 1.0× 122 1.5k
Claus G. Haase Germany 14 566 1.0× 164 0.4× 192 0.8× 328 1.4× 269 1.3× 28 1.4k
Brad A. Bryan United States 27 1.2k 2.0× 291 0.8× 123 0.5× 487 2.1× 274 1.3× 63 2.1k
Qiqun Zeng China 9 556 0.9× 178 0.5× 151 0.6× 301 1.3× 167 0.8× 9 986
Aurelio Hernández‐Laín Spain 19 456 0.8× 191 0.5× 102 0.4× 201 0.9× 165 0.8× 88 1.3k

Countries citing papers authored by Zhiguo Lin

Since Specialization
Citations

This map shows the geographic impact of Zhiguo Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiguo Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiguo Lin more than expected).

Fields of papers citing papers by Zhiguo Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhiguo Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiguo Lin. The network helps show where Zhiguo Lin may publish in the future.

Co-authorship network of co-authors of Zhiguo Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Zhiguo Lin. A scholar is included among the top collaborators of Zhiguo Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhiguo Lin. Zhiguo Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Yan, Zhibin Han, Tianyu Wang, et al.. (2025). Exploring the Immune-Related Molecular Mechanisms Underlying the Comorbidity of Temporal Lobe Epilepsy and Major Depressive Disorder through Integrated Data Set Analysis. Current Molecular Pharmacology. 17. e18761429380394–e18761429380394. 7 indexed citations
2.
Wang, Baoju, Zhibin Han, Qi Liu, et al.. (2025). Ubiquitin-conjugating enzyme E2S decreases the sensitivity of glioblastoma cells to temozolomide by upregulating PGAM1 via the interaction with OTUB2. International Journal of Biological Macromolecules. 302. 140583–140583.
3.
Han, Zhibin, Baoju Wang, Qinfang Liu, et al.. (2024). UBE2S facilitates glioblastoma progression through activation of the NF-κB pathway via attenuating K11-linked ubiquitination of AKIP1. International Journal of Biological Macromolecules. 278(Pt 1). 134426–134426. 2 indexed citations
4.
Lin, Zhiguo, Wenjing Li, Yanli Wang, et al.. (2023). SMSCs-derived sEV overexpressing miR-433-3p inhibits angiogenesis induced by sEV released from synoviocytes under triggering of ferroptosis. International Immunopharmacology. 116. 109875–109875. 13 indexed citations
5.
Guo, Qing, Shuai Shen, Gefei Guan, et al.. (2022). Cancer cell intrinsic TIM-3 induces glioblastoma progression. iScience. 25(11). 105329–105329. 33 indexed citations
7.
Gu, Yifei, et al.. (2021). Profiling Analysis of Circular RNA and mRNA in Human Temporal Lobe Epilepsy with Hippocampal Sclerosis ILAE Type 1. Cellular and Molecular Neurobiology. 42(8). 2745–2755. 9 indexed citations
8.
Li, Hu, Xingbo Cheng, Zev A. Binder, et al.. (2021). Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy. Frontiers in Oncology. 11. 640910–640910. 17 indexed citations
9.
Liu, Zhendong, Jialin Wang, Zhibin Han, et al.. (2021). Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients. Molecular Medicine. 27(1). 52–52. 16 indexed citations
10.
Gu, Yifei, Tianyu Wang, Haiyang Wang, et al.. (2021). Study of Neuronal Apoptosis ceRNA Network in Hippocampal Sclerosis of Human Temporal Lobe Epilepsy by RNA-Seq. Frontiers in Neuroscience. 15. 770627–770627. 13 indexed citations
11.
Zhang, Haihong, Jinghui Feng, Zhiguo Lin, et al.. (2020). Identification and Analysis of Genes Underlying Bone Mineral Density by Integrating Microarray Data of Osteoporosis. Frontiers in Cell and Developmental Biology. 8. 798–798. 11 indexed citations
12.
Wang, Guangzhi, Jia Shen, Jiahang Sun, et al.. (2017). Cyclophilin A Maintains Glioma-Initiating Cell Stemness by Regulating Wnt/β-Catenin Signaling. Clinical Cancer Research. 23(21). 6640–6649. 45 indexed citations
13.
Wang, Jiabin, Fenghua Liu, Haitao Ge, et al.. (2017). Identifying survival-associated modules from the dysregulated triplet network in glioblastoma multiforme. Journal of Cancer Research and Clinical Oncology. 143(4). 661–671. 22 indexed citations
14.
Guo, Mian, Xiaoming Zhang, Guangzhi Wang, et al.. (2015). miR-603 promotes glioma cell growth via Wnt/β-catenin pathway by inhibiting WIF1 and CTNNBIP1. Cancer Letters. 360(1). 76–86. 60 indexed citations
16.
Meng, Na, Chuncheng Xie, Haiyang Wang, Hong Shen, & Zhiguo Lin. (2014). Calvarial defects and Dandy-Walker malformation in association with neurofibromatosis type 1. Chinese Medical Journal. 127(6). 1187–1188. 2 indexed citations
17.
Meng, Na, Haitao Ge, Shi Chen, et al.. (2014). Long-term seizure outcome for international consensus classification of hippocampal sclerosis: A survival analysis. Seizure. 25. 141–146. 36 indexed citations
18.
Lin, Zhiguo, et al.. (2012). Effect of simvastatin on chronic temporal epilepsy in rats. Chinese Journal of Neuromedicine. 11(3). 250–253. 1 indexed citations
19.
Chen, Xiao‐Guang, Xiaohua Hou, Wenpeng Gao, et al.. (2010). Morphology of the Adult Midsagittal Brainstem in Relation to the Reference Systems. Academic Radiology. 17(6). 708–717. 2 indexed citations
20.
Lin, Zhiguo. (2004). The model of pedestrian disturbing in micro-traffic simulation. Technology and Economy in Areas of Communications. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026